We are live on ! Find out more
KOSP

K O S PHARMACEUTICALS INC
KOSP

Delisted

KOSP was delisted on the 14th of December, 2006.

1 hedge funds and large institutions have $58.3K invested in K O S PHARMACEUTICALS INC in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $51K → $58.3K (+$7.3K)

0% more funds holding

Funds holding: 11 (0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
RWM
RMG Wealth Management
Wisconsin
+$5.53K

Top Sellers

No sellers this quarter

KOSP Hedge Fund Activity: Q3 2025 in Review

1 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q3 2025, worth a combined $58.3K — up 14% from $51K a quarter earlier.

Fund positioning in KOSP was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was RMG Wealth Management, adding an estimated $5.53K.

  • 1 institutional investor held K O S PHARMACEUTICALS INC (KOSP) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $58.3K of K O S PHARMACEUTICALS INC stock for Q3 2025, up 14% quarter-over-quarter.
  • 0 funds opened new K O S PHARMACEUTICALS INC positions in Q3 2025 and 0 closed out.
  • The largest K O S PHARMACEUTICALS INC buyer in Q3 2025 was RMG Wealth Management, an estimated $5.53K added.

Based on aggregated 13F filings for Q3 2025.